| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
4-Hydroxy Nebivolol
|
178383-76-1 |
4-羟基奈必洛尔
|
4-羟基奈必洛尔;4-羟基奈比洛尔(非对映体的混合物)
|
C22H28ClF2NO6 |
475.910626 | |
|
(-)-Nebivolol
|
118457-16-2 |
奈比洛尔杂质(L-奈必洛尔)
|
奈比洛尔EP杂质A;奈比洛尔杂质(L-奈必洛尔);奈必洛尔杂质A;奈比诺尔杂质对照品
|
C22H25F2NO4 |
405.435 | |
|
Edoxaban Impurity 3
|
480452-37-7 |
依度沙班杂质F(单体)
|
EDOXABAN-6;依度沙班杂质F(单体);N1-(5-氯吡啶-2-基)-N2-((1S,2R,4S)-2-氨基-4-[(二甲基氨基)羰基]环己基)乙二酰胺二甲磺酸盐(单体)
|
C2H4N2O2 |
88.06536 | |
|
Acetazolamide EP Impurity F
|
80495-47-2 |
乙酰唑胺杂质
|
|
C8H9N7O6S4 |
427.46036 | |
|
Tenofovir disoproxil Impurity 17
|
1246812-43-0 |
替诺福韦二聚
|
泰诺福韦酯甲酯杂质;富马酸替诺福韦酯杂质;替诺福韦二聚;[2-(6-氨基-嘌呤-9-基)-1-甲基-乙氧基甲基]膦酸甲氧羰基氧甲基酯异丙氧基羰基氧基甲基酯;单型腔二聚体;[2-(6-氨基-嘌呤-9-基)-1-甲基-乙氧基甲基]膦酸乙氧羰基氧甲基酯异丙氧基羰基氧基甲基酯;TENOFOVIR DISOPROXIL-3;O-(甲氧羰基氧甲基)-O-(异丙氧基羰基氧基甲基)-{(R)-[1-(6-氨基-9H-嘌呤-9-基)丙-2-基氧基]}甲基膦酰基
|
C18H28N5O10P |
505.416181 | |
|
Δ2-Cefepime
|
88040-25-9 |
CEFEPIME
|
|
C23H34N6O6S2 |
554.68266 | |
|
Benserazide Impurity 4
|
3614-72-0 |
BENSERAZIDE IMPURITY
|
BENSERAZIDE IMPURITY;苄丝肼杂质4;2,3,4-三羟基苄基肼甲氧化物;BENSERAZIDE IMPURITY
|
C7H10N2O3.CH4O |
202.21 | |
|
7-ACT
|
58909-56-1 |
头孢曲松杂质E
|
头孢曲松杂质E;头孢曲松钠EP杂质E;原料药头孢曲松钠 杂质E;(6R-反式)-7-氨基-8-氧代-3-[[(1,2,5,6-四氢-2-甲基-5,6-二氧代-1,4-三嗪-3-基)硫代]甲基]-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸;头孢曲松EP杂质E
|
C12H13N5O5S2 |
371.39212 | 261-491-7 |
|
Tenofovir Related Compound 8
|
1883563-86-7 |
替诺福韦拉酚氨酯杂质1
|
泰诺福韦杂质8;替诺福韦艾拉酚胺杂质8/杂质IM-C;替诺福韦拉酚氨酯杂质01;替诺福韦甲酰胺杂质2;替诺福韦艾拉酚胺杂质C;替诺福韦艾拉酚胺杂质01;替诺福韦艾拉酚胺杂质1;TENOFOVIR ALAFENAMIDE-1
|
|||
|
Benzhexol Impurity 7
|
344890-62-6 |
BENZHEXOL(TRIHEXYPHENIDYL)
|
Benzhexol Impurity 6 HCl
|
|||
|
Cefixime EP Impurity B
|
1335475-19-8 |
头孢克肟杂质B
|
头孢克肟杂质B;头孢克肟EP杂质B;头孢克肟杂质B(EP)
|
C15H17N5O6S2 |
427.45538 | |
|
Valacyclovir Impurity 18
|
124832-28-6 |
D-发昔洛韦盐酸盐
|
缬昔洛韦EP杂质R;D-发昔洛韦盐酸盐
|
C13H21ClN6O4 |
360.79664 | |
|
Rosuvastatin EP Impurity G (Calcium Salt)
|
1242184-42-4 |
(3S,5R)-瑞舒伐他汀
|
瑞舒伐他汀钙EP杂质G(3S5R);(3S,5R)-瑞舒伐他汀;ROSUVASTATIN CALCIUM-8;瑞舒伐他汀杂质G;瑞舒伐他汀钙EP杂质G;瑞舒伐他汀EP杂质G;EP杂质G;瑞舒伐他汀EP杂质G(钙盐)
|
C22H28FN3O6S |
481.5376232 | |
|
Rosuvastatin Impurity 7(Calcium Salt)
|
854898-53-6 |
瑞舒伐他汀杂质
|
瑞舒伐他汀相关化合物17;瑞舒伐他汀相关化合物20;瑞舒伐他汀5-甲氧基脱叉杂质;瑞舒伐他汀3-甲氧基脱叉杂质;瑞舒伐他汀钙盐异构体光降解-8;瑞舒伐他汀杂质;瑞舒伐他汀光降解杂质2;瑞舒伐他汀G4-2((6S)-ISOMER)
|
C22H27FN3O6S·Na |
481.539 | |
|
Flupirtine Impurity 13
|
736866-91-4 |
氟吡汀杂质6
|
氟吡汀杂质06;FLUPIRTINE-5
|
C19H22N4O6 |
286.32902 | |
|
Desloratadine EP Impurity A
|
298220-99-2 |
11-氟地氯雷他定
|
11-氟地氯雷他定;地氯雷他定EP杂质A;去氯雷他定EP杂质A
|
C19H20ClFN2 |
330.826903 | |
|
Duloxetine EP Impurity A
|
910138-96-4 |
度洛西汀杂质
|
Duloxetine impurity 2/Duloxetine EP Impurity A HCl/(R)-Duloxetine Hydrochloride;Duloxetine Related CoMpound A;(3R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine HCl;R-DULOXETINE HYDROCHLORIDE;Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine Hydrochloride);Duloxetine iMpurity;(R)-N-Methyl-3-(1-naphthoxy)-3-(2-thienyl)propylaMine Hydrochloride;(γR)-N-Methyl-γ-(1-naphthalenyloxy)-2-thiophenepropanaMine Hydrochloride
|
C18H20ClNOS |
333.8755 | |
|
Dapagliflozin Hydroxy Impurity
|
960404-86-8 |
达格列净杂质1
|
(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol;Hydroxy Dapagliflozin;Dapagliflozin impurity 4/Dapagliflozin Hydroxy impurity;1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose
|
|||
|
Vinpocetine Impurity 21
|
55821-92-6 |
长春西汀杂质24
|
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]phthyridine-12-carboxylate;Vinpocetine-23;sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate;Eburnamenine-14-carboxylic acid, 14,15-dihydro-, (3α,16α)
|
|||
|
Hyoscine Butylbromide Impurity E Hydrochloride (N-Butylhyoscine Hydrochloride)
|
22235-98-9 |
N-BUTYL NOR SCOPOLAMINE HYDROCHLORIDE
|
|
C20H28ClNO4 |
381.89362 |
药智官方微信
药智官方微博
